156 related articles for article (PubMed ID: 9721346)
1. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
Pérez-Páramo M; Muñoz J; Albillos A; Rossi I; Alvarez-Mon M; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(4):294-301. PubMed ID: 9721346
[TBL] [Abstract][Full Text] [Related]
2. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats.
Muñoz J; Albillos A; Pérez-Páramo M; Rossi I; Alvarez-Mon M
Am J Physiol; 1999 Mar; 276(3):G687-93. PubMed ID: 10070045
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
4. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
[TBL] [Abstract][Full Text] [Related]
6. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
9. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
11. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
Wang CT; Kuang YL; Chen ZP
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
[TBL] [Abstract][Full Text] [Related]
12. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic and systemic hemodynamic alterations in chronic, progressive portal hypertensive rats.
Blanchart A; Garrido MC; Fernández-Muñoz D; Nuño J; Hernando L; López-Novoa JM
Rev Esp Fisiol; 1984 Dec; 40(4):493-9. PubMed ID: 6397796
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
15. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J
Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
[TBL] [Abstract][Full Text] [Related]
16. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
[TBL] [Abstract][Full Text] [Related]
17. [The effect of PGI2 on formation and development of hyperdynamic circulatory state in portal hypertensive rats].
Wu ZY; Chen XS; Cao H
Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):537-40. PubMed ID: 12921664
[TBL] [Abstract][Full Text] [Related]
18. Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting.
Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM
Clin Physiol Biochem; 1990; 8(3):144-52. PubMed ID: 2225722
[TBL] [Abstract][Full Text] [Related]
19. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].
Zhou YB; Leng X; Qi G
Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats.
Lopez-Talavera JC; Merrill WW; Groszmann RJ
Gastroenterology; 1995 Mar; 108(3):761-7. PubMed ID: 7875478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
